Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study

Author:

Jodal Henriette C.123ORCID,Akwiwu Eddymurphy U.4ORCID,Lemmens Margriet5ORCID,Delis-van Diemen Pien M.5ORCID,Klotz Dagmar16ORCID,Leon Leticia G.5ORCID,Lakbir Soufyan57ORCID,de Wit Meike5ORCID,Fijneman Remond J.A.5ORCID,van Leerdam Monique E.89ORCID,Dekker Evelien10ORCID,Spaander Manon C.W.11ORCID,Meijer Gerrit A.5ORCID,Løberg Magnus12ORCID,Coupé Veerle M.H.4ORCID,Kalager Mette12ORCID,Carvalho Beatriz5ORCID

Affiliation:

1. 1Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.

2. 2Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway.

3. 3Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.

4. 4Department of Epidemiology and Data Science, Amsterdam Public Health Research Group, Amsterdam University Medical Centers, Location VU Medical Center, Amsterdam, the Netherlands.

5. 5Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

6. 6Department of Pathology, Oslo University Hospital, Oslo, Norway.

7. 7Bioinformatics Group, Department of Computer Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

8. 8Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

9. 9Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.

10. 10Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, the Netherlands.

11. 11Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

Abstract

Abstract Current morphologic features defining advanced adenomas (size ≥10 mm, high-grade dysplasia or ≥25% villous component) cannot optimally distinguish individuals at high risk or low risk of metachronous colorectal cancer (me-CRC), which may result in suboptimal surveillance. Certain DNA copy-number alterations (CNAs) are associated with adenoma-to-carcinoma progression. We aimed to evaluate whether these molecular features can better predict an individual's risk of me-CRC than the morphologic advanced adenoma features. In this nested case–control study, 529 individuals with a single adenoma at first colonoscopy were selected from a Norwegian adenoma cohort. DNA copy-number profiles were determined, by low-coverage whole-genome sequencing. Prevalence of CNAs in advanced and non-advanced adenomas and its association (OR) with me-CRC was assessed. For the latter, cases (with me-CRC) were matched to controls (without me-CRC) on follow-up, age and sex. CNAs associated with adenoma-to-carcinoma progression were observed in 85/267 (32%) of advanced adenomas and in 27/262 (10%) of non-advanced adenomas. me-CRC was statistically significantly associated, also after adjustment for other variables, with age at baseline [OR, 1.14; 95% confidence interval CI), 1.03–1.26; P = 0.012], advanced adenomas (OR, 2.46; 95% CI, 1.50–4.01; P < 0.001) and with the presence of ≥3 DNA copy-number losses (OR, 1.90; 95% CI. 1.02–3.54; P = 0.043). Molecularly-defined high-risk adenomas were associated with me-CRC, but the association of advanced adenoma with me-CRC was stronger. Significance: Identifying new biomarkers may improve prediction of me-CRC for individuals with adenomas and optimize surveillance intervals to reduce risk of colorectal cancer and reduce oversurveillance of patients with low risk of colorectal cancer. Use of DNA CNAs alone does not improve prediction of me-CRC. Further research to improve risk classification is required.

Funder

ZonMw

Norges Forskningsråd

Publisher

American Association for Cancer Research (AACR)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3